Daniel Rudeklint
Amministratore Delegato presso EMOTRA AB (PUBL)
Profilo
Mr. Daniel Rudeklint, CPA, is a President, Chief Executive Officer, CFO & Director at Emotra AB and a Chief Financial Officer & Director at Peptonic Medical AB.
He is on the Board of Directors at KebNi AB, Emotra AB and Peptonic Medical AB.
He received his graduate degree from Luleå University of Technology.
Posizioni attive di Daniel Rudeklint
| Società | Posizione | Inizio |
|---|---|---|
| EMOTRA AB (PUBL) | Amministratore Delegato | 01/11/2021 |
| PEPTONIC MEDICAL AB | Direttore Finanziario/CFO | 15/05/2024 |
| KEBNI AB | Direttore/Membro del Consiglio | 01/06/2022 |
Formazione di Daniel Rudeklint
| Luleå University of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PEPTONIC MEDICAL AB | Health Technology |
| KEBNI AB | Electronic Technology |
| Aziende private | 1 |
|---|---|
Emotra AB
 Emotra AB Medical SpecialtiesHealth Technology Emotra AB engages in the research and development of physiological and statistical methods for psychiatric care. It offers a medical device that tests the psychophysiological being of patients suffering from depression through their responses to sound signals. The company was founded by Elizabeth Kaminski and Lars-Håkan Thorell on June 18, 2001 and is headquartered in Molndal, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Daniel Rudeklint
